Meningitis B row shows flaws in how vaccine de... - CLL Support

CLL Support

22,532 members38,709 posts

Meningitis B row shows flaws in how vaccine decisions are made (NICE - UK)

AussieNeil profile image
AussieNeilAdministrator
1 Reply

The current UK debate over whether the Meningitis B vaccine should be extended to children over 1 year old might result in a shake-up of the NICE rules for approving treatments which under the current rules are not approved. "The vaccine was introduced for babies under 1 year old in September 2015, but the government says it isn’t cost-effective for older children.

Meningitis is one of the most feared childhood illnesses because of the way it can progress with terrifying speed to kill or maim those who were running around just the day before. The justification for withholding the shot is that meningitis B is rare, affecting only a few hundred children a year – so the benefits of vaccinating all children and teenagers look small next to most other things the NHS does.

:

The parliamentary petition to give the new meningitis B vaccine to all UK children has had more than 800,000 signatures – the highest number on record.

:

There are several problems with the modelling study on which the decision was based. One is that the extent to which the vaccine prevents disability was worked out using a scale designed for adults. It asks, for instance, if the person can dress without help or is depressed, questions that don’t easily translate to young children.

Secondly, the model gauged the vaccine’s costs and benefits using a system that some say fails to give due weight to future health..." (my emphasis)

Full article from New Scientist (Free registration may be required)

newscientist.com/article/20...

Neil

Written by
AussieNeil profile image
AussieNeil
Administrator
To view profiles and participate in discussions please or .
Read more about...
1 Reply
PaulaS profile image
PaulaSVolunteer

After I'd had my spleen removed, I was given vaccinations for Meningitis B and C.  The meningitis C came as part of the Menitorix Vacc, which also contains HiB (haemophilus influenzae type B).  Some CLL doctors give those to all their CLL patients - even those who DO still have spleens (as well as giving Prevnar and Pneumovax for pneumonia.)   

Scrol down to the second chart in the following: (thanks PKenn) cdc.gov/vaccines/schedules/...

It might be worth asking our docs about the meningitis and HiB vacc, (and not just the two Pneumonia ones).  I'll all for getting as much protection as we can. I'm aware that CLL,  people often  don't get a very good response, (and some folk don't get any response at all).  But it seems worth a try...   

Paula

You may also like...

Germany says Astrazeneca's vaccine is not for over 65s, European regulator statement due tomorrow.

regarding the current shortfall in supply of vaccine. The European Medicines Agency, which has been...

U.S. advisory group lays out detailed recommendations on how to prioritize Covid-19 vaccine

expects pushback especially as when Covid-19 vaccines are approved for use, initial supplies will...

Treatment Coverage Under Medicare

covered at 100% under Part B. If it is considered a pharmaceutical and covered under Part D, there...

NHS decision takes away Ibrutinib from patients

d-effective-drug-to-cut-costs-zv30zrk2k NICE, the agency which had approved the drug for CLL...

The price of freedom?

Life is a lottery. I came across this article earlier which puts an estimate at 500 000 on the...